Cargando…

Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability

INTRODUCTION: Expanding naloxone availability is important to reduce opioid-related deaths. Recent data suggest low, variable urban naloxone availability. No reports describe naloxone availability at the point of sale (POSN). We characterize POSN without prescription across a Midwestern metropolitan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olives, Travis, Willhite, Laurie A., Lee, Samantha C., Evans, Danika K., Jensen, Ashley, Regelman, Hsiao-Ting, McGillis, Eric S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Department of Emergency Medicine, University of California, Irvine School of Medicine 2020
Materias:	Behavioral Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7514389/ https://www.ncbi.nlm.nih.gov/pubmed/32970574 http://dx.doi.org/10.5811/westjem.7.2020.47252

Ejemplares similares

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

Nobody Wants to Be Narcan’d: A Pilot Qualitative Analysis of Drug Users’ Perspectives on Naloxone
por: Lai, Jeffrey T., et al.
Publicado: (2021)

Implementation of a Leave-behind Naloxone Program in San Francisco: A One-year Experience
por: LeSaint, Kathy T., et al.
Publicado: (2022)

Naloxone Audit
por: Venan, Paster
Publicado: (2023)

Naloxone availability in independent community pharmacies in Georgia, 2019
por: Gilbert, Lauren, et al.
Publicado: (2021)

Does Housing Status Matter in Emergency Medical Services Administration of Naloxone? A Prehospital Cross-sectional Study
por: Abramson, Tiffany M., et al.
Publicado: (2023)

Naloxone distribution and possession following a large‐scale naloxone programme
por: Madah‐Amiri, Desiree, et al.
Publicado: (2018)

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019)

Impact of California Statute on Naloxone Availability and Opioid Overdose Rates
por: Gallant, Tara L., et al.
Publicado: (2023)

Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
por: Guadamuz, Jenny S., et al.
Publicado: (2019)

Use of naloxone in valproate overdose
por: Sanaei-Zadeh, Hossein
Publicado: (2012)

Effects of naloxone on phagocyte functions
por: Delvaux, B, et al.
Publicado: (2006)

Naloxone induced pulmonary edema
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire
por: Bolivar, Derek, et al.
Publicado: (2023)

Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors
por: Enich, Michael, et al.
Publicado: (2023)

Ramipril poisoning rescued by naloxone and terlipressin
por: Samanta, Samanta, et al.
Publicado: (2014)

The Emergency Department as an Opportunity for Naloxone Distribution
por: Gunn, Alexander H., et al.
Publicado: (2018)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis‐generating Small Clinical Studies
por: Gufford, BT, et al.
Publicado: (2017)

Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates
por: Gangal, Neha S., et al.
Publicado: (2020)

Evaluation of a large-scale health department naloxone distribution program: Per capita naloxone distribution and overdose morality
por: Freiermuth, Caroline E., et al.
Publicado: (2023)

Assessment of naloxone as a therapeutic for inhaled carfentanil in the ferret
por: McCranor, Bryan J., et al.
Publicado: (2020)

Reply: Matching Minute Ventilation in the Hypermetabolic State of Dinitrophenol Poisoning
por: McGillis, Eric S., et al.
Publicado: (2020)

Stress-Induced Antinociception in Fish Reversed by Naloxone
por: Wolkers, Carla Patrícia Bejo, et al.
Publicado: (2013)

The place of oxycodone/naloxone in chronic pain management
por: Leppert, Wojciech
Publicado: (2013)

Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal
por: Overbeek, Daniel L., et al.
Publicado: (2019)

Public perceptions of naloxone use in the outpatient setting
por: Smith, Jordan O., et al.
Publicado: (2019)

Medicaid prescription limits and their implications for naloxone accessibility
por: Roberts, Andrew W., et al.
Publicado: (2021)

Considering the Potential Benefits of Over-the-Counter Naloxone
por: Evoy, Kirk E, et al.
Publicado: (2021)

The status of naloxone in community pharmacies across Canada
por: So, Randy, et al.
Publicado: (2020)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Closed-loop wearable naloxone injector system
por: Chan, Justin, et al.
Publicado: (2021)

Rapid Absorption of Naloxone from Eye Drops
por: Tuunainen, Johanna, et al.
Publicado: (2022)

Two Cases of Dextromethorphan Overdose Reversed by Naloxone
por: Kumar, Dhruva, et al.
Publicado: (2023)

Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
por: Straus, Michele M, et al.
Publicado: (2013)

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level
por: Moss, Ronald B., et al.
Publicado: (2020)

Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN(®) Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
por: Tippey, Kathryn G., et al.
Publicado: (2019)

Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_179mqf48uhl2tdd1rtidttqb8d